Is it time for equity in the treatment of severe VWD and haemophilia A?. Join us at #EAHAD2025 on Wednesday, February 5, at 17:15 to discuss the latest advancements in the treatment of patients with VWD: #vwd #vonwillebranddisease

Join us for our symposium "A New Era in Precision Hemostasis" at #ANES24 today, 5:30 - 7 PM in Room 120B. Let's #See, #Touch, #Link, and #Learn together! .#LifeSciences #CriticalCare.

Meet the Octapharma team at #ANES24! Visit Booth #12083 to #See, #Touch, #Link, and #Learn with us. Excited to connect!.

We’re thrilled to be part of #ANES24! Visit Octapharma at Booth #12083 from Oct 18 - 22. Let’s #See, #Touch, #Link, and #Learn together. #LifeSciences #CriticalCare

#AIinhealthcare is revolutionising the diagnosis and treatment of primary immunodeficiencies. Join Manish Butte, Elie Haddad, and Helen Leavis at the Octapharma symposium at #ESID2024 on Oct 18, 12:15 CET to explore the latest breakthroughs:

Primary immunodeficiencies are rare, with diverse symptoms causing delays in diagnosis and treatment. Advancements in #AIinhealthcare show great promise in revolutionising care. Join us at #ESID2024 on Oct 18, 12:15 CET to explore the latest breakthroughs!.

Karin (1,400+ donations) and Mike (1,200+) are dedicated plasma donors at Octapharma Plasma. This International Plasma Awareness Week (Oct 7-11), we honor heroes like them—the heart of our lifesaving mission. #IPAW2024.

Fortunately, Deni’s #haemophilia was diagnosed early, but many other haemophilia patients in Indonesia remain undiagnosed or receive inadequate care. Deni now shares his story to raise awareness of this life-changing disease. Read the article here:

Critical medical conditions in combination with life-threatening #bleeding require effective interventions. Yet, evidence and standards remain limited, leading to variable patient outcomes. Octapharma collaborates globally to enhance bleeding management. Explore our efforts

Our Under the Spotlight symposium is starting soon at #ISTH2024! Join us at 12:15 ICT in Room 210, or watch it live on One Source: For HCPs only.

Our Under the Spotlight symposium is starting soon at #ISTH2024! Join us at 12:15 ICT in Room 208 or virtually on One Source: For HCPs only.

Data on the use of #IVIG in Chronic Inflammatory Demyelinating Polyneuropathy (#CIDP) will be presented at #PNS2024. Attending on site in Montreal? Visit us at exhibit table #25!. Learn more: For HCPs only.

Octapharma Hybrid Update-in-Hematology session starts soon at #EHA2024. Join us at Hall N103 at 16:15 CEST!

#EHA2024 is around the corner! During the Octapharma Hybrid Update-in-Hematology, leading experts discuss the management of the infection burden in multiple myeloma and beyond. Join the interactive session on June 14 at 16:15 CEST. See all details here:

Over the past two decades, Octapharma USA, Inc. has achieved many milestones, securing multiple FDA approvals and successfully passing inspections of all Octapharma production sites. Today, we offer a portfolio of ten FDA-registered products in the USA. Read the full story here:

Maria Isabel has lived with CVID, a primary immunodeficiency disease (#PID), for her entire life. To help break the stigma of PIDs around the world, she wants other patients to know that it is possible to live a full life with proper treatment. Watch her full story here:

Are you attending #WFH2024? Join our Under the Spotlight symposium with Victor Jiménez Yuste, Robert F. Sidonio Jr., Craig Kessler, Viola Vogel and Robert Klamroth on Monday, April 22 at 18:30. See the agenda here: The symposium is for HCPs only.

RT @PabloMaura: En el #DíaMundialdelaHemofilia, en @OctapharmaGroup España, nos unimos al #RetoPrendaRoja de @fedhemo y al #RetolaGota de @….

When Deni was growing up in Jakarta during the 1990s, treatment for #haemophilia was not widely available in Indonesia. Despite progress, gaps in addressing bleeding disorders persist. Raising awareness is crucial for improving the diagnosis and treatment of bleeding disorders